Table 2.
Characteristics of medication reconciliation during safety net primary and specialty care visits (n=35).
| Medication reconciliation characteristics | Value | ||
| Medication reconciliation duration (minutes), median (IQRa) | 2.1 (1.0-4.4) | ||
| % of medication reconciliation time spent performing activities, median (IQR) |
|
||
|
|
Multitasking EHRb use | 47 (26-70) | |
|
|
Silent EHR use | 0 (0-6) | |
|
|
Non-EHR multitasking | 0 (0-13) | |
|
|
Focused patient-clinician talk | 24 (0-39) | |
| Number of total medicationsc, median (IQR) | 13 (9-17) | ||
| Number of relevant medicationsc, median (IQR) | 7 (5-12) | ||
| Number of relevant medications addressedd, median (IQR) | 2 (1-5) | ||
aIQR: interquartile range.
bEHR: electronic health record.
cThe total medications included all listed in the patient’s note or discussed during the visit encounter. All medications were categorized as relevant for primary care encounters. For specialty care encounters, relevant medications were related to the clinician’s specialty and those with drug or disease interactions.
dMedications were categorized as “addressed” if the patient or clinician specifically discussed its current use.